US Patent 9822173 Heterodimeric immunoglobulins
Patent 9822173 was granted and assigned to Amgen on November, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9822173 Heterodimeric immunoglobulins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.